Myasthenia Gravis (MG)

Myasthenia gravis is an autoimmune disease where the immune system attacks the body’s own tissues, interrupting the connection between nerves and muscles.

Blog Post

Clinical Trial Alert: Phase 2/3 Study of an Investigational Medication in Pediatric Patients with Generalized Myasthenia Gravis

By Sujatha Gurunathan | October 4, 2023
Blog Post

Clinical Trial Alert: Phase 3 Study of Batoclimab in Adults with MG

By Sujatha Gurunathan | September 29, 2023
Blue and red graphic design of an inviting hospital emergency room.
Featured Article

Smart Steps to Take in a Medical Emergency

By Darlene Demetri | August 8, 2023
Blog Post

FDA Approves argenx’s Vyvgart Hytrulo for Treatment of gMG

By Sujatha Gurunathan | June 20, 2023
Family portrait of mother and father smiling with two young girls in a field
Blog Post

How One Family’s Myasthenia Gravis Journey is Helping Others

By Rebecca Hume | June 9, 2023
Mature Asian man doctors medical results during consultation on tablet computer with woman patient in health clinic. Medical health care concept.
Blog Post

Why Is It So Hard to Get a Diagnosis?

By Shaila Wunderlich | May 11, 2023
Green background with word Clinical Trial Alert and a picture of scientists in a lab
Blog Post

Clinical Trial Alert: Phase 3 Study of Pozelimab and Cemdisiran in Adults with gMG

By Sujatha Gurunathan | April 26, 2023
Blog Post

Simply Stated: Elevated Enzymes

By Sharon Hesterlee, Evrim Atas, and Angela Lek | April 6, 2023
Clinical Trial Alert with image of researcher's gloved hand holding a test tube
Blog Post

Clinical Trial Alert: Phase 2 Study of ALXN2050 in Adults with Generalized Myasthenia Gravis (gMG)

By Sujatha Gurunathan | March 9, 2023
Blog Post

MDA Announces Advocacy Collaboration Grants Recipients

By Mark Fisher | February 16, 2023